Effect of multimedia in radiology reports.
Hyperlinked multimedia-enhanced radiology reports improve concordance of target lesion selection and measurements used to calculate therapeutic response, according to a study published in the American Journal of Roentgenology.
Researchers from the National Institutes of Health Clinical Center in Bethesda, MD, performed a retrospective study determine the clinical value of hyperlinked tumor measurements in multimedia-enhanced radiology reports in the PACS and the inclusion of a radiologist assistant in the process of assessing tumor burden.
The researchers assessed 489 target lesions in 232 CT examinations of 71 patients with metastatic genitourinary cancer enrolled in two therapeutic trials. Target lesion selection and measurement concordance between oncology records (used to calculate therapeutic response) and two types of radiology reports in the PACS were analyzed, as well as multimedia-enhanced radiology reports and text-only reports.
The results showed that the concordance on target lesion selection was greater for multimedia-enhanced radiology reports, at 78%, than the text-only reports, which were at 52%. The researchers also noted improved overall measurement concordance with the multimedia-enhanced radiology reports, at 68%, compared with the text-only reports, at 38%.
“Compared with text-only reports, hyperlinked multimedia-enhanced radiology reports improved concordance of target lesion selection and measurement with the measurements used to calculate therapeutic response,” the researchers concluded.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.